ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) Declares $0.08 Quarterly Dividend

ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIBGet Free Report) announced a quarterly dividend on Tuesday, September 22nd. Investors of record on Wednesday, September 23rd will be given a dividend of 0.0826 per share by the exchange traded fund on Tuesday, September 29th. This represents a c) annualized dividend and a dividend yield of 0.3%. The ex-dividend date of this dividend is Wednesday, September 23rd.

ProShares Ultra Nasdaq Biotechnology Trading Down 4.4%

BIB traded down $5.12 during midday trading on Wednesday, reaching $112.04. The company’s stock had a trading volume of 10,286 shares, compared to its average volume of 11,103. The company has a fifty day simple moving average of $109.66 and a 200 day simple moving average of $93.93. The stock has a market cap of $94.11 million, a P/E ratio of 20.68 and a beta of 1.22. ProShares Ultra Nasdaq Biotechnology has a twelve month low of $55.34 and a twelve month high of $126.40.

Institutional Investors Weigh In On ProShares Ultra Nasdaq Biotechnology

An institutional investor recently raised its stake in ProShares Ultra Nasdaq Biotechnology stock. Kaizen Financial Strategies raised its position in shares of ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIBFree Report) by 4.7% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 5,565 shares of the exchange traded fund’s stock after buying an additional 250 shares during the period. Kaizen Financial Strategies owned about 0.60% of ProShares Ultra Nasdaq Biotechnology worth $483,000 as of its most recent filing with the Securities and Exchange Commission.

ProShares Ultra Nasdaq Biotechnology Company Profile

(Get Free Report)

ProShares Ultra Nasdaq Biotechnology (the Fund) seeks daily investment results, before fees and expenses, that correspond to twice (200%) the daily performance of the Index. The return of the Fund for a period longer than a single trading day will be the result of each day’s returns compounded over the period, which will very likely differ from the inverse of the return of the Dow Jones United States Basic Materials Index (the Index) for that period. The Fund does not seek to achieve its stated investment objective over a period of time greater than one day.

Recommended Stories

Dividend History for ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB)

Receive News & Ratings for ProShares Ultra Nasdaq Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ProShares Ultra Nasdaq Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.